share_log

8-K: Poll Results of 2024 Annual Meeting of Shareholders

8-K: Poll Results of 2024 Annual Meeting of Shareholders

8-K：2024年股东大会投票结果
美股sec公告 ·  05/09 16:59
Moomoo AI 已提取核心信息
Bristol-Myers Squibb Company held its Annual Meeting on May 7, 2024, where several key decisions were made by its shareholders. The election of the company's 10 nominees to the Board of Directors was confirmed, with each director receiving a significant majority of votes for their appointment until the 2025 Annual Meeting. Additionally, the advisory vote to approve the compensation of the company's named executive officers was passed. Shareholders ratified the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for 2024. A management proposal to amend the company's Amended and Restated Certificate of Incorporation for limiting executive officers' monetary liability for breach of duty of care was approved. However, two shareholder proposals, one for adopting a policy that the Chairperson of the Board be an independent director, and another concerning Executive Retention of Significant Stock, were not approved. The meeting concluded with the inclusion of a Certificate of Amendment effective as of May 7, 2024, as part of the Current Report on Form 8-K.
Bristol-Myers Squibb Company held its Annual Meeting on May 7, 2024, where several key decisions were made by its shareholders. The election of the company's 10 nominees to the Board of Directors was confirmed, with each director receiving a significant majority of votes for their appointment until the 2025 Annual Meeting. Additionally, the advisory vote to approve the compensation of the company's named executive officers was passed. Shareholders ratified the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for 2024. A management proposal to amend the company's Amended and Restated Certificate of Incorporation for limiting executive officers' monetary liability for breach of duty of care was approved. However, two shareholder proposals, one for adopting a policy that the Chairperson of the Board be an independent director, and another concerning Executive Retention of Significant Stock, were not approved. The meeting concluded with the inclusion of a Certificate of Amendment effective as of May 7, 2024, as part of the Current Report on Form 8-K.
百时美施贵宝公司于2024年5月7日举行了年会，其股东在会上做出了几项关键决定。公司的10名董事会候选人的选举得到确认，在2025年年会之前，每位董事的任命都获得了绝大多数选票。此外，批准公司指定执行官薪酬的咨询投票获得通过。股东批准任命德勤会计师事务所为2024年的独立注册会计师事务所。管理层关于修改公司经修订和重述的公司注册证书以限制执行官因违反谨慎义务而承担的金钱责任的提案获得批准。但是，两项股东提案未获批准，一项是通过董事会主席为独立董事的政策，另一项是关于高管保留重要股票的提案。会议结束时纳入了自2024年5月7日起生效的修正证书，作为8-K表最新报告的一部分。
百时美施贵宝公司于2024年5月7日举行了年会，其股东在会上做出了几项关键决定。公司的10名董事会候选人的选举得到确认，在2025年年会之前，每位董事的任命都获得了绝大多数选票。此外，批准公司指定执行官薪酬的咨询投票获得通过。股东批准任命德勤会计师事务所为2024年的独立注册会计师事务所。管理层关于修改公司经修订和重述的公司注册证书以限制执行官因违反谨慎义务而承担的金钱责任的提案获得批准。但是，两项股东提案未获批准，一项是通过董事会主席为独立董事的政策，另一项是关于高管保留重要股票的提案。会议结束时纳入了自2024年5月7日起生效的修正证书，作为8-K表最新报告的一部分。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

独立文件2  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息